Using Noise Reduction Methods in ImageJ to Produce High Quality Data
Griffin Ferrara2021-02-25T14:34:56-05:00After completing the imaging process for your desired biological model, you may find that some of your images have [...]
Leica Biosystems and Visikol to Host Multiplex Webinar
Griffin Ferrara2021-02-18T17:31:02-05:00Visikol CEO Dr. Michael Johnson will be hosting a webinar with Leica Biosystems discussing multiplex imaging and the Leica [...]
Our Multiplex Immunolabeling Approach
Griffin Ferrara2021-02-03T15:56:14-05:00Immunohistochemistry is routinely used to localize and study the distribution of proteins in tissues. Most staining methods are limited [...]
Visikol Launches BitSlide, Cloud-Based Digital Pathology Slide Visualization Platform
Griffin Ferrara2021-02-09T14:40:29-05:00Visikol has been a leader in advanced bioimaging through its portfolio of cutting-edge technologies and innovative drug discovery, bioimaging, [...]
Using Immuno- histochemistry and Multiplex Slide Labeling for Tumor Research
Griffin Ferrara2021-01-26T09:45:42-05:00Accurate prediction and prognosis as well as patient stratification for precision therapy are the most important and difficult issues [...]
Visikol Expands Hampton Facility to Accommodate Service Growth
Griffin Ferrara2021-01-18T10:32:43-05:002020 was a challenging year for all industries and the life sciences field was no exception. Throughout 2020, Visikol [...]
New Year, New Services
Griffin Ferrara2021-01-08T15:14:13-05:00We are excited to finally turn the page on 2020 and get started on 2021 and are looking forward [...]
Imaging Scientist
Mike Johnson2021-01-05T13:19:42-05:00At Visikol, our mission is to accelerate the discovery and development of therapeutics through transforming tissues into quantitative data [...]
High Content Screening for Immune Modulators
Griffin Ferrara2021-02-19T10:14:01-05:00Cancer immunotherapies that target T cells via the blockage of immune checkpoints are a promising approach for cancer treatment. [...]
Advances in Immuno-oncology
Griffin Ferrara2020-12-23T09:36:54-05:00Over the last decade there has been a boom of companies looking into immunotherapies for treating cancer [...]